523 related articles for article (PubMed ID: 11353811)
1. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
2. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
Szabados E; Literati-Nagy P; Farkas B; Sumegi B
Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
[TBL] [Abstract][Full Text] [Related]
3. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
4. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart.
Szabados E; Fischer GM; Gallyas F; Kispal G; Sumegi B
Free Radic Biol Med; 1999 Nov; 27(9-10):1103-13. PubMed ID: 10569643
[TBL] [Abstract][Full Text] [Related]
5. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of poly (ADP-ribose) polymerase inhibition against the reperfusion injury in heart transplantation.
Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nediani C; Perna AM; Liguori P; Nassi N; Formigli L; Tani A; Nassi P
Free Radic Res; 2003 Mar; 37(3):331-9. PubMed ID: 12688429
[TBL] [Abstract][Full Text] [Related]
7. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
8. The role of Akt and mitogen-activated protein kinase systems in the protective effect of poly(ADP-ribose) polymerase inhibition in Langendorff perfused and in isoproterenol-damaged rat hearts.
Pálfi A; Tóth A; Kulcsár G; Hantó K; Deres P; Bartha E; Halmosi R; Szabados E; Czopf L; Kálai T; Hideg K; Sümegi B; Tóth K
J Pharmacol Exp Ther; 2005 Oct; 315(1):273-82. PubMed ID: 15951400
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.
Bowes J; McDonald MC; Piper J; Thiemermann C
Cardiovasc Res; 1999 Jan; 41(1):126-34. PubMed ID: 10325960
[TBL] [Abstract][Full Text] [Related]
10. Neuronal trauma model: in search of Thanatos.
Cole K; Perez-Polo JR
Int J Dev Neurosci; 2004 Nov; 22(7):485-96. PubMed ID: 15465278
[TBL] [Abstract][Full Text] [Related]
11. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.
Szabados E; Fischer GM; Toth K; Csete B; Nemeti B; Trombitas K; Habon T; Endrei D; Sumegi B
Free Radic Biol Med; 1999 Feb; 26(3-4):309-17. PubMed ID: 9895221
[TBL] [Abstract][Full Text] [Related]
12. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
Lin CH; Lin PH
Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
[TBL] [Abstract][Full Text] [Related]
13. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption.
Pieper AA; Walles T; Wei G; Clements EE; Verma A; Snyder SH; Zweier JL
Mol Med; 2000 Apr; 6(4):271-82. PubMed ID: 10949908
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model.
Yamazaki K; Tanaka S; Sakata R; Miwa S; Oriyanhan W; Takaba K; Minakata K; Marui A; Ikeda T; Toyokuni S; Komeda M; Ueda K
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):143-7. PubMed ID: 22168830
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Jing Lin P
Shock; 2006 Feb; 25(2):168-75. PubMed ID: 16525356
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress.
Chatterjee PK; Cuzzocrea S; Thiemermann C
Kidney Int; 1999 Sep; 56(3):973-84. PubMed ID: 10469365
[TBL] [Abstract][Full Text] [Related]
17. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
18. Lipid peroxidation, protein thiol oxidation and DNA damage in hydrogen peroxide-induced injury to endothelial cells: role of activation of poly(ADP-ribose)polymerase.
Kirkland JB
Biochim Biophys Acta; 1991 May; 1092(3):319-25. PubMed ID: 1904775
[TBL] [Abstract][Full Text] [Related]
19. Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and beta-adrenergic receptor blockers.
Kovacs K; Hanto K; Bognar Z; Tapodi A; Bognar E; Kiss GN; Szabo A; Rappai G; Kiss T; Sumegi B; Gallyas F
Mol Cell Biochem; 2009 Jan; 321(1-2):155-64. PubMed ID: 18975057
[TBL] [Abstract][Full Text] [Related]
20. BGP-15 - a novel poly(ADP-ribose) polymerase inhibitor - protects against nephrotoxicity of cisplatin without compromising its antitumor activity.
Racz I; Tory K; Gallyas F; Berente Z; Osz E; Jaszlits L; Bernath S; Sumegi B; Rabloczky G; Literati-Nagy P
Biochem Pharmacol; 2002 Mar; 63(6):1099-111. PubMed ID: 11931842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
